IL154803A0 - New process for the production of oxabispidines - Google Patents

New process for the production of oxabispidines

Info

Publication number
IL154803A0
IL154803A0 IL15480301A IL15480301A IL154803A0 IL 154803 A0 IL154803 A0 IL 154803A0 IL 15480301 A IL15480301 A IL 15480301A IL 15480301 A IL15480301 A IL 15480301A IL 154803 A0 IL154803 A0 IL 154803A0
Authority
IL
Israel
Prior art keywords
oxabispidines
production
new process
new
Prior art date
Application number
IL15480301A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/SE2000/001994 external-priority patent/WO2001028992A2/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL154803A0 publication Critical patent/IL154803A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL15480301A 2000-10-02 2001-10-01 New process for the production of oxabispidines IL154803A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PH12000002701 2000-10-02
PCT/SE2000/001994 WO2001028992A2 (en) 1999-10-18 2000-10-13 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
PCT/SE2001/002130 WO2002028864A1 (en) 2000-10-02 2001-10-01 New process for the production of oxabispidines

Publications (1)

Publication Number Publication Date
IL154803A0 true IL154803A0 (en) 2003-10-31

Family

ID=52573779

Family Applications (3)

Application Number Title Priority Date Filing Date
IL15480201A IL154802A0 (en) 2000-10-02 2001-10-01 New oxabispidine compound useful in the treatment of cardiac arrhythmias
IL15480301A IL154803A0 (en) 2000-10-02 2001-10-01 New process for the production of oxabispidines
IL154803A IL154803A (en) 2000-10-02 2003-03-06 Process for the production of oxbispidines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL15480201A IL154802A0 (en) 2000-10-02 2001-10-01 New oxabispidine compound useful in the treatment of cardiac arrhythmias

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154803A IL154803A (en) 2000-10-02 2003-03-06 Process for the production of oxbispidines

Country Status (22)

Country Link
US (5) US20040039199A1 (is)
EP (3) EP1330462A1 (is)
JP (2) JP4248873B2 (is)
KR (2) KR100812920B1 (is)
CN (3) CN1468244A (is)
AR (1) AR030756A1 (is)
AU (3) AU9250401A (is)
BR (2) BR0114366A (is)
CA (2) CA2422810A1 (is)
CZ (1) CZ294217B6 (is)
EE (1) EE200300131A (is)
HU (1) HUP0302288A3 (is)
IL (3) IL154802A0 (is)
IS (1) IS6744A (is)
MX (2) MXPA03002759A (is)
NO (2) NO20031413L (is)
NZ (2) NZ524573A (is)
PL (1) PL364047A1 (is)
RU (1) RU2003107668A (is)
SK (1) SK3862003A3 (is)
WO (2) WO2002028863A1 (is)
ZA (2) ZA200301757B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
GB0223712D0 (en) * 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
AR057064A1 (es) 2005-06-13 2007-11-14 Astrazeneca Ab Compuestos para el tratamiento de arritmias cardiacas, formulacion farmaceutica y preparacion del compuesto
WO2006137769A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes
BRPI0611841A2 (pt) * 2005-06-20 2016-08-30 Astrazeneca Ab processos para isolar um sal, para preparar um sal, e para a preparação de um composto
AR053901A1 (es) * 2005-06-20 2007-05-23 Astrazeneca Ab Formas fisicas de oxabispidinas n,n'- disustituidas
EP1915380A4 (en) * 2005-06-20 2010-03-17 Astrazeneca Ab PROCESS FOR THE SYNTHESIS OF N, N'-DISUBSTITUTED OXABISPIDINES
CN103319423B (zh) * 2013-06-28 2015-10-28 江苏师范大学 一种3,7-双芳基-1,5-二氧-3,7-二氮杂环辛烷的合成方法
KR20150082070A (ko) 2014-01-06 2015-07-15 (주)신비넷 위치 인식 시스템 및 그 시스템에서의 위치 인식을 위한 장치 및 방법
EP3059229A1 (en) 2015-02-17 2016-08-24 Evonik Degussa GmbH Method for the epoxidation of an olefin with hydrogen peroxide
CN115054728B (zh) * 2022-07-18 2023-11-07 中国科学院大学宁波华美医院 一种仿生骨组织工程支架材料及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3503939A (en) * 1967-03-29 1970-03-31 Du Pont Polyamides from heterocyclic diamines
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE3112055A1 (de) * 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
DE3902357A1 (de) 1989-01-27 1990-08-02 Hoechst Ag Verwendung von rheniumorganischen verbindungen zur oxidation von c-c-mehrfachbindungen, darauf basierende oxidationsverfahren und neue rheniumorganische verbindungen
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5110933A (en) 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
US5468858A (en) * 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
US5831099A (en) 1995-03-10 1998-11-03 The United States Of America As Represented By The Secretary Of The Army Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same
US5939568A (en) 1997-01-31 1999-08-17 The Scripps Research Institute Accelerated catalysis of olefinic epoxidations
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
NZ514477A (en) * 1999-04-09 2003-04-29 Astrazeneca Ab Adamantane derivatives
AUPQ274199A0 (en) 1999-09-09 1999-09-30 Ericsson Australia Pty Ltd Information transmission rate control across a core network
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
GB0223712D0 (en) * 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate

Also Published As

Publication number Publication date
IL154802A0 (en) 2003-10-31
RU2003107668A (ru) 2004-11-27
NO20031413D0 (no) 2003-03-27
IL154803A (en) 2008-03-20
CN1243754C (zh) 2006-03-01
WO2002028863A8 (en) 2003-06-05
EP1330462A1 (en) 2003-07-30
CN1468245A (zh) 2004-01-14
US20050171100A1 (en) 2005-08-04
EE200300131A (et) 2003-06-16
US20090036675A1 (en) 2009-02-05
SK3862003A3 (en) 2003-10-07
EP1900741A8 (en) 2010-08-04
IS6744A (is) 2003-03-13
PL364047A1 (en) 2004-12-13
BR0114366A (pt) 2003-08-12
KR20030032061A (ko) 2003-04-23
CA2421776A1 (en) 2002-04-11
ZA200301757B (en) 2004-02-05
ZA200302202B (en) 2004-06-28
CA2422810A1 (en) 2002-04-11
KR20030032060A (ko) 2003-04-23
US6936712B1 (en) 2005-08-30
US20040039199A1 (en) 2004-02-26
AU9250401A (en) 2002-04-15
KR100812920B1 (ko) 2008-03-11
HUP0302288A2 (hu) 2003-10-28
NO20031414L (no) 2003-05-26
US20090240051A1 (en) 2009-09-24
NZ524573A (en) 2004-11-26
US7439355B2 (en) 2008-10-21
CN1793146A (zh) 2006-06-28
CN1468244A (zh) 2004-01-14
MXPA03002679A (es) 2003-06-24
AU2001292504B2 (en) 2006-09-07
CZ294217B6 (cs) 2004-10-13
WO2002028864A1 (en) 2002-04-11
MXPA03002759A (es) 2003-07-28
JP4248873B2 (ja) 2009-04-02
WO2002028863A1 (en) 2002-04-11
CZ2003923A3 (cs) 2003-08-13
HUP0302288A3 (en) 2004-11-29
AU2001292503A1 (en) 2002-04-15
NO20031413L (no) 2003-05-22
JP2004510776A (ja) 2004-04-08
AR030756A1 (es) 2003-09-03
JP2004510775A (ja) 2004-04-08
NO20031414D0 (no) 2003-03-27
EP1900741A1 (en) 2008-03-19
BR0114367A (pt) 2003-12-09
NZ524574A (en) 2004-11-26
EP1330461A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
EG22541A (en) Process for the production of olefins
HUP0000283A3 (en) New process for the production of quetiapine
GB2381524B (en) Process for the production of xylitol
GC0000309A (en) Process for the production of melamine
AU9250401A (en) New process for the production of oxabispidines
HUP0200567A3 (en) Process for the fermentative production of o-acetyl-serin
AU2001230207A1 (en) Method for the production of 1-amino-3-aryl-uracils
TWI318975B (en) Process for the production of ethers
AU9168301A (en) Method for the production of melamine
HUP0202530A2 (en) Method for the production of phosphonomethylglycin
AU8824201A (en) Process for the preparation of dinapsoline
HUP0103554A2 (en) Method for production of methylene-karbamide polimers
AU2002234066A1 (en) Process for the production of amides
EP1281723A4 (en) NEW PROCESS FOR THE PREPARATION OF POLYACETYLENE DERIVATIVES
HU0104563D0 (en) Process for producing of food-enzymes
IL158119A0 (en) Method for the production of delta1-pyrrolines
GC0000365A (en) Process for the production of olefins
IL149713A0 (en) Process for the production of trifluormethylacetophenones
HUP0301141A3 (en) Method for the production of trioxime derivatives
HUP0001408A2 (hu) Eljárás takarmánymagok előállítására
EP1293497A4 (en) PROCESS FOR PRODUCING CALCIUM PENTOTHENATE
GB0007768D0 (en) Process for the production of olefins
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
HU0001373D0 (en) Process for production salamimass differ cross sectional
IL156421A0 (en) Method for the production of alkenes

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: IN JOURNAL 1/2008 P. 326 PATENT APPLICATION NO. 154803 CORRECT PRIORITY CLAIM TO- PCT/SE00/01994 13.10.2000 SE

FF Patent granted
KB Patent renewed